Skip to main content
Journal cover image

Microbiome analyses in patients with previously treated, deficient DNA mismatch repair/microsatellite instability-high metastatic colorectal cancer treated with nivolumab +/- ipilimumab: CheckMate 142

Publication ,  Conference
Kopetz, S; Zagonel, V; Overman, MJ; McDermott, R; Morse, MA; Chen, FL; Lee, J; Moss, RA; Ling, L; Greenfield, A; Greenawalt, D; Cao, ZA
Published in: JOURNAL FOR IMMUNOTHERAPY OF CANCER
November 7, 2017

Duke Scholars

Published In

JOURNAL FOR IMMUNOTHERAPY OF CANCER

ISSN

2051-1426

Publication Date

November 7, 2017

Volume

5

Publisher

BMC

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kopetz, S., Zagonel, V., Overman, M. J., McDermott, R., Morse, M. A., Chen, F. L., … Cao, Z. A. (2017). Microbiome analyses in patients with previously treated, deficient DNA mismatch repair/microsatellite instability-high metastatic colorectal cancer treated with nivolumab +/- ipilimumab: CheckMate 142. In JOURNAL FOR IMMUNOTHERAPY OF CANCER (Vol. 5). BMC.
Kopetz, Scott, Vittorina Zagonel, Michael J. Overman, Ray McDermott, Michael A. Morse, Franklin L. Chen, James Lee, et al. “Microbiome analyses in patients with previously treated, deficient DNA mismatch repair/microsatellite instability-high metastatic colorectal cancer treated with nivolumab +/- ipilimumab: CheckMate 142.” In JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol. 5. BMC, 2017.
Kopetz S, Zagonel V, Overman MJ, McDermott R, Morse MA, Chen FL, Lee J, Moss RA, Ling L, Greenfield A, Greenawalt D, Cao ZA. Microbiome analyses in patients with previously treated, deficient DNA mismatch repair/microsatellite instability-high metastatic colorectal cancer treated with nivolumab +/- ipilimumab: CheckMate 142. JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2017.
Journal cover image

Published In

JOURNAL FOR IMMUNOTHERAPY OF CANCER

ISSN

2051-1426

Publication Date

November 7, 2017

Volume

5

Publisher

BMC

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology